Abstract bekijken

Deze abstract is toegekend aan sessie Ped & Low - Pediatric Ophthalmology and Low-Vision
TitelOcular side effects of Vigabatrin in children
Abstract Nr.1079
DoelVigabatrin is an inhibitor of GABA transaminase used for the treatment of infantile spasms and epilepsy refractory to others treatments. Unfortunately, it can be associated with permanent peripheral visual field defects that are difficult to detect in young patients.

The purpose is to update the recommended ophthalmologic follow up of children taking Vigabatrin.
MethodesA literature review of visual loss related to Vigabatrin is presented. The screening tests, such as ophthalmoscopy, automated visual fields, SD OCT, ERG, VEP, will be reviewed.
ResultatenEpileptic patients may have visual defects not attributed to Vigabatrin. In non-verbal, uncooperative young patients, ophthalmoscopy is recommended at baseline and every 3 months
ConclusiePeriodic dilated ophthalmoscopy is the best method to avoid unnecessary cessation of this valuable medication in epileptic young patient.
BelangenverstrengelingNee
Auteur 1
NaamYOUSSFI
InitialenAY
InstituutHôpital Erasme
StadBruxelles
top ^